麻醉类型对经颈动脉血运重建术中不良事件的影响
该研究基于2012至2021年全球质量保证项目中27043例经颈动脉血运重建术(TCAR),比较全身麻醉(GA)与局部或区域麻醉(LRA)的围术期临床和技术不良事件及术中操作指标。结果显示两组临床不良事件、技术不良事件及术中操作指标均无显著差异。
要点
- 83%的TCAR在全身麻醉下完成,且该比例随时间增加(R²=0.74;P<.0001)。
- GA组与LRA组围术期临床不良事件(1.49% vs 1.55%;P=.78)和技术不良事件(5.6% vs 5.3%;P=.47)均无显著差异。
- 两组术中操作指标(血流逆转时间、透视时间、对比剂用量、皮肤至皮肤时间)无差异。
核心结论
- 近三分之二的医生仅在全麻下实施TCAR,且全麻比例随时间增加。
- 严重内科危险因素患者中接受LRA的比例高于GA,而解剖危险因素患者中接受GA的比例更高。
- 围术期临床和技术不良事件不因麻醉类型而异,术中操作指标两组相似。
- 麻醉选择可能驱动的操作成本差异需进一步研究。
研究设计与样本
- 全球质量保证项目中连续TCAR手术的回顾性分析,共27043例TCAR,由1456名医生于2012至2021年完成。
- 数据由马里兰大学血管研究中心独立分析,采用泊松回归评估麻醉类型对不良事件率的影响,线性回归比较操作指标。
主要发现
- 83%的患者接受GA,该比例随时间增加(R²=0.74;P<.0001)。
- 33.4%的医生在某些手术中使用LRA,仅2.7%的医生在所有手术中使用LRA。
- LRA组临床危险因素更常见(P<.0001),GA组解剖危险因素更常见(P<.0001),后续分析已调整这些差异。
- 血管外科医生和既往经股动脉颈动脉支架经验更丰富的医生更可能使用LRA(P<.0001)。
- GA vs LRA:临床不良事件1.49%(95%CI 1.3-1.8)vs 1.55%(95%CI 1.2-2.0),P=.78;技术不良事件5.6%(95%CI 5.2-6.2)vs 5.3%(95%CI 4.5-6.3),P=.47;术中操作指标无差异。
关键数值与推荐
- 临床不良事件复合终点包括死亡、卒中、短暂性脑缺血发作、心肌梗死。
- 技术不良事件复合终点包括手术中止、转为颈动脉内膜切除术、出血、夹层、颅神经损伤、器械失败。
- 术中操作指标包括血流逆转时间、透视时间、对比剂用量、皮肤至皮肤时间。
临床怎么用
- 原文未据此给出推荐。
局限性
- 麻醉选择可能驱动的操作成本差异需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The use of local or regional anesthesia (LRA) is encouraged during transcarotid artery revascularization (TCAR) because the procedure is performed through a small incision. LRA permits neurologic evaluation during the procedure and may reduce periprocedural cardiac morbidity compared with general anesthesia (GA). There is limited and conflicting information regarding the preferred anesthesia to use during TCAR. We compared periprocedural clinical and technical complications, and intraprocedural performance metrics of TCAR performed under GA vs LRA. METHODS: Patient, lesion, physician, and procedural information was collected in a worldwide quality assurance program of consecutive TCAR procedures. A composite clinical adverse event rate (death, stroke, transient ischemic attack, myocardial infarction) and a composite technical adverse event rate (aborted procedure, conversion to carotid endarterectomy, bleeding, dissection, cranial-nerve injury, device failure) in the periprocedural period were computed. Four intraprocedural performance measures (flow-reversal time, fluoroscopy time, contrast volume, and skin-to-skin time) were recorded. Deidentified data were analyzed independently at the Center for Vascular Research, University of Maryland. Poisson regressions were used to assess the impact of anesthesia type on adverse event rates. Linear regressions were used to compare performance measures. RESULTS: A total of 27,043 TCARs were performed by 1456 physicians between 2012 and 2021. A majority of patients (83%) received GA, and this proportion increased over time (R2 = 0.74; P < .0001). Some physicians (33.4%) used LRA in some of their procedures; only 2.7% used LRA in all of their procedures. Clinical risk factors were more common in the LRA group (P < .0001) and anatomic risk factors in the GA group (P < .0001); these differences were adjusted for in subsequent analyses. LRA was more likely to be used by vascular surgeons and by physicians with higher prior transfemoral carotid stenting experience (P < .0001). When comparing GA vs LRA, clinical adverse events (1.49%; 95% confidence interval [CI], 1.3-1.8 vs 1.55%; 95% CI, 1.2-2.0; P = .78), technical adverse events (5.6%; 95% CI, 5.2-6.2 vs 5.3%; 95% CI, 4.5-6.3; P = .47), and intraprocedural performance measures did not differ by type of anesthesia. CONCLUSIONS: Almost two-thirds of physicians performed TCAR exclusively under GA, and the overall proportion of procedures performed under GA increased over time. A larger fraction of patients with severe medical risk factors received LRA vs GA, whereas a larger fraction of patients with anatomic risk-factors received GA. Periprocedural clinical and technical adverse events did not differ by type of anesthesia. Intraprocedural performance metrics that drive procedural cost were similar between groups; potential differences in procedural cost driven by anesthetic choice require further study.
引用
- Lal BK, Mayorga-Carlin M, Sahoo S, et al. Impact of the type of anesthesia on adverse events during transcarotid artery revascularization. J Vasc Surg. 2024. PMID: 39179003. doi:10.1016/j.jvs.2024.07.091
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。